Product Code: ETC10627759 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Meningioma Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Meningioma Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Meningioma Market - Industry Life Cycle |
3.4 Israel Meningioma Market - Porter's Five Forces |
3.5 Israel Meningioma Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Meningioma Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Israel Meningioma Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Meningioma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of meningioma cases in Israel |
4.2.2 Technological advancements in diagnosis and treatment of meningioma |
4.2.3 Growing awareness and early detection of meningioma among the population |
4.3 Market Restraints |
4.3.1 High cost of treatment for meningioma |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Israel |
4.3.3 Stringent regulatory requirements for approval of new treatments |
5 Israel Meningioma Market Trends |
6 Israel Meningioma Market, By Types |
6.1 Israel Meningioma Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Meningioma Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Israel Meningioma Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.1.4 Israel Meningioma Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.1.5 Israel Meningioma Market Revenues & Volume, By Medication, 2021 - 2031F |
6.2 Israel Meningioma Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Meningioma Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Israel Meningioma Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Israel Meningioma Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Israel Meningioma Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Israel Meningioma Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Meningioma Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Israel Meningioma Market Revenues & Volume, By Others, 2021 - 2031F |
7 Israel Meningioma Market Import-Export Trade Statistics |
7.1 Israel Meningioma Market Export to Major Countries |
7.2 Israel Meningioma Market Imports from Major Countries |
8 Israel Meningioma Market Key Performance Indicators |
8.1 Average age at diagnosis of meningioma cases in Israel |
8.2 Number of healthcare facilities offering specialized meningioma treatment |
8.3 Percentage of meningioma patients receiving timely diagnosis and treatment |
9 Israel Meningioma Market - Opportunity Assessment |
9.1 Israel Meningioma Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Meningioma Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Israel Meningioma Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Meningioma Market - Competitive Landscape |
10.1 Israel Meningioma Market Revenue Share, By Companies, 2024 |
10.2 Israel Meningioma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |